Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.31 |
| ▸ | CACNG8 | Q8WXS5 | 1/20 | 0.31 |
| ▸ | CACNG2 | Q9Y698 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21707013 | 0.92 | L3MBTL1 (0.37) | KDM4EATML3MBTL1KMT2A | |
| SCHEMBL21707003 | 0.89 | NR3C1 (0.32) | NR3C1NPSR1RXFP1MAPK14GRIA1 | |
| SCHEMBL21707000 | 0.88 | NR3C1 (0.35) | NR3C1NPSR1RXFP1MAPK14GRIA1 | |
| SCHEMBL16138709 | 0.85 | KDM4E (0.37) | NR3C1NPSR1RXFP1MAPK14GRIA1 | |
| SCHEMBL21706996 | 0.83 | NR3C1 (0.40) | NR3C1NPSR1RXFP1MAPK14GRIA1 | |
| SCHEMBL21706816 | 0.83 | NR3C1 (0.38) | NR3C1NPSR1RXFP1MAPK14GRIA1 | |
| SCHEMBL21706856 | 0.83 | NR3C1 (0.38) | NR3C1NPSR1RXFP1MAPK14GRIA1 | |
| SCHEMBL21706815 | 0.83 | NR3C1 (0.35) | NR3C1NPSR1RXFP1MAPK14GRIA1 | |
| SCHEMBL22244777 | 0.81 | L3MBTL1 (0.42) | KDM4EATML3MBTL1KMT2A | |
| SCHEMBL22244457 | 0.81 | L3MBTL1 (0.42) | KDM4EATML3MBTL1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200052223-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200052223-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | NR3C1 714/4885NPSR1 4395/4885RXFP1 3748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.